Open-Label Extension Study of Trofinetide for Rett Syndrome
Clinical trial NCT04776746 · TERMINATED
Trial details
- NCT number
- NCT04776746
- Sponsor
- ACADIA Pharmaceuticals Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-08
- Primary completion
- 2023-06-30
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.